drugset / Trial / NCT02478333
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of ALS-008176 following oral administration of single ascending dose of ALS-008176 in healthy Japanese adult participants.
Timeline
- Start
- 2015-05
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumicitabine | Small molecule | 250 mg | Oral |
| Subject | Lumicitabine | Small molecule | 500 mg | Oral |
| Subject | Lumicitabine | Small molecule | 750 mg | Oral |